Series production in Germany moves closer as company prepares for portfolio expansion

We are working on a broader portfolio of applications across medical, lifestyle and professional care. The next step will be the introduction of a dedicated lifestyle offering.”

— Dr. Achim Müller, Founder & CTO

GROßOSTHEIM, GERMANY, September 25, 2026 /EINPresswire.com/ — FiberSense™ AG (“FiberSense™”) has reached an important manufacturing milestone with the first filling of sensor fibers on its new automated filling line in Großostheim, Germany.

The new production setup automates a key step in the manufacture of the company’s high-tech biosensors and supports FiberSense’s™ transition towards reproducible and scalable series production.

“This is an important step as we prepare FiberSense™ for the next stage of growth,” commented Chairman & CEO, Michael Tillmann.

“Scaling an innovative sensing technology is not only about developing the product itself – it’s also about building the manufacturing capabilities needed to produce consistently and at scale. Automating this key production step brings us another step closer to that goal.”

FiberSense’s ™sensing platform is based on the company’s proprietary photometric technology and will form the foundation for a broader continuous metabolic monitoring portfolio, with further applications and product lines already in development.

“As we expand our product architecture under the FiberSense™ CxM umbrella, the manufacturing capabilities we are building here in Germany allow us to translate our technology into scalable products and prepare for sustainable future growth,” explained Dario Clos, who led the implementation of the new filling line.

FiberSense™ Founder & CTO Dr Achim Müller added that the same industrialisation capabilities will support not only the company’s new FiberSense™ CGM system for diabetes care, but also future applications based on the underlying sensing platform.

The CE-marked FiberSense™ CGM system combines a 28-day wear cycle with a reusable detector and is set to launch in Q1 2027.

“We are working on a broader portfolio of applications across medical, lifestyle and professional care,” Müller revealed. “The next step will be the introduction of a dedicated lifestyle offering, which we plan to launch next month.”

FiberSense AG
+49 6026 942121398
email us here
FiberSense Media
Visit us on social media:
LinkedIn
X

Legal Disclaimer:

EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Media gallery

About The Author
Written By: EIN Presswire